Popular weight loss drugs like Ozempic and Mounjaro are now linked to rare but serious cases of acute pancreatitis, including ...

Sales of Eli Lilly’s Mounjaro double in a month; Novo Nordisk’s Wegovy enters market amid rising obesity and diabetes rates.

Incidence of obesity and diabetes is rising in India, the world's most populous country, which also ranks among the worst ...

Obesity is a common risk factor for several serious health conditions like diabetes, heart disease, hypertension, fatty liver ...

A NEW study challenges the idea that weight loss jabs decrease muscle mass, alongside fat. Scientists say one injection – ...

CVS Caremark has removed coverage of Zepbound, a GLP-1 weight-loss drug, citing pricing concerns and shifting payer dynamics ...

ALONG with rapid fat loss, weight loss jabs have been linked to a decrease in muscle mass. But scientists say one injection – ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

School districts across Minnesota are struggling to contain double-digit health insurance cost increases. Some officials say ...

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...